| Tissue Specificity | Higher expression in normal tissues than in tumor cell lines. Highly expressed in peripheral blood lymphocytes, spleen, skeletal muscle, placenta, lung and heart. |
| Post Translational Modifications | N-glycosylated and O-glycosylated. |
| Function | Receptor for the cytotoxic ligand TRAIL. Lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. May protect cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand. |
| Protein Name | Tumor Necrosis Factor Receptor Superfamily Member 10cAntagonist Decoy Receptor For Trail/Apo-2lDecoy Trail Receptor Without Death DomainDecoy Receptor 1Dcr1Lymphocyte Inhibitor Of TrailTnf-Related Apoptosis-Inducing Ligand Receptor 3Trail Receptor 3Trail-R3Trail Receptor Without An Intracellular DomainCd Antigen Cd263 |
| Database Links | Reactome: R-HSA-6803211 |
| Cellular Localisation | Cell MembraneLipid-AnchorGpi-Anchor |
| Alternative Antibody Names | Anti-Tumor Necrosis Factor Receptor Superfamily Member 10c antibodyAnti-Antagonist Decoy Receptor For Trail/Apo-2l antibodyAnti-Decoy Trail Receptor Without Death Domain antibodyAnti-Decoy Receptor 1 antibodyAnti-Dcr1 antibodyAnti-Lymphocyte Inhibitor Of Trail antibodyAnti-Tnf-Related Apoptosis-Inducing Ligand Receptor 3 antibodyAnti-Trail Receptor 3 antibodyAnti-Trail-R3 antibodyAnti-Trail Receptor Without An Intracellular Domain antibodyAnti-Cd Antigen Cd263 antibodyAnti-TNFRSF10C antibodyAnti-DCR1 antibodyAnti-LIT antibodyAnti-TRAILR3 antibodyAnti-TRID antibodyAnti-UNQ321 antibodyAnti-PRO366 antibody |
Information sourced from Uniprot.org
